After CCl4 dosing for 4 weeks and 8 weeks, CebpaΔHep mice had higher hepatic Spp1 mRNA, serum OPN, liver fibrosis, and hepatic CD45 staining (Figure 7, A–C). Here, PTPRC is linked to Hepatic fibrosis.